Gene Therapy for Subjects With RPGR Mutation-associated X-linked Retinitis Pigmentosa
NCT05874310
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
X-Linked Retinitis Pigmentosa
Interventions
GENETIC:
FT-002
Sponsor
Frontera Therapeutics
Collaborators
[object Object]
[object Object]
[object Object]